These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7735484)

  • 1. Quantification of an 11C-labelled beta-adrenoceptor ligand, S-(-)CGP 12177, in plasma of humans and rats.
    van Waarde A; Anthonio RL; Visser TJ; Elsinga PH; Posthumus H; Weemaes AM; Blanksma PK; Visser GM; Paans AM; Vaalburg W
    J Chromatogr B Biomed Appl; 1995 Jan; 663(2):361-9. PubMed ID: 7735484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of (S)-4-(3-(2'-[11C]isopropylamino)-2-hydroxypropoxy) -2H-benzimidazol -2-one ((S)-[11C]CGP 12388) and (S)-4-(3-((1'-[18F]-fluoroisopropyl)amino)-2-hydroxypropoxy) -2H- benzimidazol-2-one ((S)-[18F]fluoro-CGP 12388) for visualization of beta-adrenoceptors with positron emission tomography.
    Elsinga PH; van Waarde A; Jaeggi KA; Schreiber G; Heldoorn M; Vaalburg W
    J Med Chem; 1997 Nov; 40(23):3829-35. PubMed ID: 9371248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of the beta-adrenoceptor ligand S-1'-[18F]fluorocarazolol in plasma of humans, rats and sheep.
    van Waarde A; Visser TJ; Posthumus H; Elsinga PH; Anthonio RL; van Loenen-Weemaes AM; Visser GM; Beaufort-Krol GC; Paans AM; Vaalburg W
    J Chromatogr B Biomed Appl; 1996 Apr; 678(2):253-60. PubMed ID: 8738029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid analysis for metabolites of 11C-labelled drugs: fate of [11C]-S-4-(tert.-butylamino-2-hydroxypropoxy)-benzimidazol-2-one in the dog.
    Jones HA; Rhodes CG; Law MP; Becket JM; Clark JC; Boobis AR; Taylor GW
    J Chromatogr; 1991 Oct; 570(2):361-70. PubMed ID: 1686775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel beta-adrenoceptor ligand for positron emission tomography: evaluation in experimental animals.
    van Waarde A; Elsinga PH; Doze P; Heldoorn M; Jaeggi KA; Vaalburg W
    Eur J Pharmacol; 1998 Feb; 343(2-3):289-96. PubMed ID: 9570478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suitability of CGP-12177 and CGP-26505 for quantitative imaging of beta-adrenoceptors.
    van Waarde A; Meeder JG; Blanksma PK; Bouwer J; Visser GM; Elsinga PH; Paans AM; Vaalburg W; Lie KI
    Int J Rad Appl Instrum B; 1992 Oct; 19(7):711-8. PubMed ID: 1356953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of [11C]GB67, a novel radioligand for imaging myocardial alpha 1-adrenoceptors with positron emission tomography.
    Law MP; Osman S; Pike VW; Davenport RJ; Cunningham VJ; Rimoldi O; Rhodes CG; Giardinà D; Camici PG
    Eur J Nucl Med; 2000 Jan; 27(1):7-17. PubMed ID: 10654141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and preliminary evaluation of (R,S)-1-[2-((carbamoyl-4-hydroxy)phenoxy)-ethylamino]-3-[4-(1-[11C]-met hyl-4-trifluoromethyl-2-imidazolyl)phenoxy]-2-propanol ([11C]CGP 20712A) as a selective beta 1-adrenoceptor ligand for PET.
    Elsinga PH; Van Waarde A; Visser GM; Vaalburg W
    Nucl Med Biol; 1994 Feb; 21(2):211-7. PubMed ID: 9234285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of beta2-adrenoceptors, using the agonist [11C]formoterol and positron emission tomography.
    Visser TJ; van Waarde A; Doze P; Elsinga PH; van der Mark TW; Kraan J; Ensing K; Vaalburg W
    Eur J Pharmacol; 1998 Nov; 361(1):35-41. PubMed ID: 9851539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are [O-methyl-11C]derivatives of ICI 89,406 beta1-adrenoceptor selective radioligands suitable for PET?
    Law MP; Wagner S; Kopka K; Pike VW; Schober O; Schäfers M
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):174-85. PubMed ID: 17906860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric synthesis of a precursor for the automated radiosynthesis of S-(3'-t-butylamino-2'-hydroxypropoxy)-benzimidazol-2-[11C]one (S-[11C]CGP 12177) as a preferred radioligand for beta-adrenergic receptors.
    Brady F; Luthra SK; Tochon-Danguy HJ; Steel CJ; Waters SL; Kensett MJ; Landais P; Shah F; Jaeggi KA; Drake A
    Int J Rad Appl Instrum A; 1991; 42(7):621-8. PubMed ID: 1685153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of the suitability of CGP 12177 for in vivo studies of beta-adrenoceptors.
    Law MP
    Br J Pharmacol; 1993 Aug; 109(4):1101-9. PubMed ID: 8104642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of radioligands by rat heart and lung in vivo: CGP 12177 does and CGP 26505 does not reflect binding to beta-adrenoceptors.
    Van Waarde A; Meeder JG; Blanksma PK; Brodde OE; Visser GM; Elsinga PH; Paans AM; Vaalburg W; Lie KI
    Eur J Pharmacol; 1992 Nov; 222(1):107-12. PubMed ID: 1361437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo quantification of pulmonary beta-adrenoceptor density in humans with (S)-[11C]CGP-12177 and PET.
    Ueki J; Rhodes CG; Hughes JM; De Silva R; Lefroy DC; Ind PW; Qing F; Brady F; Luthra SK; Steel CJ
    J Appl Physiol (1985); 1993 Aug; 75(2):559-65. PubMed ID: 7901192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Esmolol, an ultrashort-acting, selective beta 1-adrenoceptor antagonist: pharmacodynamic and pharmacokinetic properties.
    Volz-Zang C; Eckrich B; Jahn P; Schneidrowski B; Schulte B; Palm D
    Eur J Clin Pharmacol; 1994; 46(5):399-404. PubMed ID: 7957532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of [O-methyl-11C]RS-15385-197 as a positron emission tomography radioligand for central alpha2-adrenoceptors.
    Hume SP; Hirani E; Opacka-Juffry J; Osman S; Myers R; Gunn RN; McCarron JA; Clark RD; Melichar J; Nutt DJ; Pike VW
    Eur J Nucl Med; 2000 May; 27(5):475-84. PubMed ID: 10853800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity of (-)-[3H]-CGP 12177A as a radioligand for the 'putative beta4-adrenoceptor' in rat atrium.
    Sarsero D; Molenaar P; Kaumann AJ
    Br J Pharmacol; 1998 Feb; 123(3):371-80. PubMed ID: 9504376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.
    Brahmadevara N; Shaw AM; MacDonald A
    Br J Pharmacol; 2004 Jun; 142(4):781-7. PubMed ID: 15205310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of beta-adrenoceptors on rat skeletal muscle cells grown in vitro.
    Disatnik MH; Sampson SR; Shainberg A
    Biochem Pharmacol; 1990 Sep; 40(5):1043-8. PubMed ID: 1975171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of a low beta 1-adrenoceptor selectivity of [3H]CGP-12177 for resolving subtype-selectivity of competitive ligands.
    Nanoff C; Freissmuth M; Schütz W
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Nov; 336(5):519-25. PubMed ID: 2893983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.